Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival

Citation
Folio, C., Zalacain, M., Zandueta, C., Ormazábal, C., Sierrasesúmaga, L., Julián, M. S., de las Rivas, J., Toledo, G., Lecanda, F., & Patiño-García, A. (2012). Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival. Cancer Biomarkers, 10(1), 35–41. https://doi.org/10.3233/cbm-2012-0227
DOI:
DOI: 10.3233/CBM-2012-0227
Year of publication:
2011
Authors participating in BCBHub:
Javier De Las Rivas